AEGON Asset Management (UK)’s ResMed RMD Stock Holding History

AEGON Asset Management (UK)’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-14,418	Closed	-$1.12M	–	213
2017 Q2	$1.12M	Sell	14,418 -441	-3%	-$31.6K	0.03%	161
2017 Q1	$1.07M	Sell	14,859 -234	-2%	-$16.2K	0.03%	172
2016 Q4	$937K	Sell	15,093 -798	-5%	-$48.9K	0.03%	177
2016 Q3	$1.03M	Buy	15,891 +3,753	+31%	+$250K	0.03%	161
2016 Q2	$768K	Buy	+12,138	New	+$716K	0.02%	179
2015 Q3	–	Sell	-18,164	Closed	-$1.02M	–	209
2015 Q2	$1.02M	Buy	+18,164	New	+$1.15M	0.03%	168

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AEGON Asset Management (UK)'s RMD Position: Q3 2017 in Review

AEGON Asset Management (UK) sold out of ResMed (RMD) in Q3 2017, closing a stake of 14,418 shares — an estimated $1.12M sold.

AEGON Asset Management (UK) first reported a position in RMD in Q2 2015 and held it in 6 quarters. The position peaked at $1.12M in Q2 2017. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

AEGON Asset Management (UK) reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
AEGON Asset Management (UK) sold 14,418 ResMed shares in Q3 2017, an estimated $1.12M.
AEGON Asset Management (UK) first reported a position in ResMed in Q2 2015 and held it in 6 quarters.
AEGON Asset Management (UK)'s ResMed position peaked at $1.12M in Q2 2017.
362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on AEGON Asset Management (UK)'s 13F filing for Q3 2017, filed 8 Nov 2017.